Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kim Karsenberg"'
Publikováno v:
Clinical and Translational Science, Vol 13, Iss 1, Pp 11-13 (2020)
Externí odkaz:
https://doaj.org/article/96ad8bb56795494db72b5ad76366f08d
Publikováno v:
Cts-Clinical and Translational Science, 13, 1, pp. 11-13
Clinical and Translational Science, 13, 11-13. Wiley-Blackwell Publishing Ltd
CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 13(1), 11-13. Wiley-Blackwell
Clinical and Translational Science
Cts-Clinical and Translational Science, 13, 11-13
Clinical and Translational Science, Vol 13, Iss 1, Pp 11-13 (2020)
Clinical and Translational Science, 13, 11-13. Wiley-Blackwell Publishing Ltd
CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 13(1), 11-13. Wiley-Blackwell
Clinical and Translational Science
Cts-Clinical and Translational Science, 13, 11-13
Clinical and Translational Science, Vol 13, Iss 1, Pp 11-13 (2020)
Despite a growing interest in, and commitment to, implementing pediatric clinical trials, approximately one in every five trials in children fails because of inappropriate study design, suboptimal experiment planning, or inadequate participant enroll
Autor:
Frank E. Bellot, Frits S.A.M. van Dam, Wim H. van Harten, Rudi M. H. Roumen, Valesca P. Retèl, J. Marjan Hummel, Cees van Krimpen, Jolien M. Bueno-de-Mesquita, Kirsten F. L. Douma, Marc J. van de Vijver, Sabine C. Linn, Kim Karsenberg
Publikováno v:
International journal of technology assessment in health care, 25(1), 73-83. Cambridge University Press
Objectives:Constructive Technology Assessment (CTA) is a means to guide early implementation of new developments in society, and can be used as an evaluation tool for Coverage with Evidence Development (CED). We used CTA for the introduction of a new
Autor:
Kirsten F. L. Douma, Wim H. van Harten, J. Marjan Hummel, Kim Karsenberg, Jolien M. Bueno-de-Mesquita
Publikováno v:
International journal of technology assessment in health care, 23(2), 162-168. Cambridge University Press
Objectives: Technologies in health care are evolving quickly, with new findings in the area of biotechnological and genetic research being published regularly. A health technology assessment (HTA) is often used to answer the question of whether the n
Autor:
Annuska M. Glas, Frank E. Bellot, Douwe Atsma, Cees van Krimpen, Kirsten F. L. Douma, Frits S.A.M. van Dam, Tin S. Wu, Johannes L. Peterse, Harm van Tinteren, Valesca P. Retèl, Sjoerd Rodenhuis, Jelle Wesseling, Jolien M. Bueno-de-Mesquita, Emiel J. Th. Rutgers, Wim H. van Harten, Guido Brink, Rudi M. H. Roumen, Sabine C. Linn, Marc J. van de Vijver, Arno Floore, Kim Karsenberg, Laura J. van't Veer
Publikováno v:
The Lancet, 8(12), 1079-1089. Elsevier
lancet oncology, 8(12), 1079-1087. Lancet Publishing Group
lancet oncology, 8(12), 1079-1087. Lancet Publishing Group
Summary Background A microarray-based 70-gene prognosis signature might improve the selection of patients with node-negative breast cancer for adjuvant systemic treatment. The main aims of this MicroarRAy PrognoSTics in Breast CancER (RASTER) study w
Autor:
Valesca P. Ret?l, Jolien M. Bueno-de-Mesquita, Marjan J. M. Hummel, Marc J. van de Vijver, Kirsten F. L. Douma, Kim Karsenberg, Frits S. A. M. van Dam, Cees van Krimpen, Frank E. Bellot, Rudi M. H. Roumen, Sabine C. Linn, Wim H. van Harten
Publikováno v:
International Journal of Technology Assessment in Health Care; Jan2009, Vol. 25 Issue 1, p73-83, 11p